chr1-103691518-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PP3_Strong
The ENST00000330330.10(AMY1B):c.971G>A(p.Gly324Glu) variant causes a missense change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000050 ( 0 hom., cov: 1)
Exomes 𝑓: 0.000064 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
AMY1B
ENST00000330330.10 missense
ENST00000330330.10 missense
Scores
5
6
5
Clinical Significance
Conservation
PhyloP100: 7.47
Genes affected
AMY1B (HGNC:475): (amylase alpha 1B) Amylases are secreted proteins that hydrolyze 1,4-alpha-glucoside bonds in oligosaccharides and polysaccharides, and thus catalyze the first step in digestion of dietary starch and glycogen. The human genome has a cluster of several amylase genes that are expressed at high levels in either salivary gland or pancreas. This gene encodes an amylase isoenzyme produced by the salivary gland. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.971
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMY1B | NM_001008218.2 | c.971G>A | p.Gly324Glu | missense_variant | 7/11 | ENST00000330330.10 | NP_001008219.1 | |
AMY1B | NM_001386925.1 | c.971G>A | p.Gly324Glu | missense_variant | 7/11 | NP_001373854.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMY1B | ENST00000330330.10 | c.971G>A | p.Gly324Glu | missense_variant | 7/11 | 1 | NM_001008218.2 | ENSP00000330484 | P1 | |
AMY1B | ENST00000370080.7 | c.971G>A | p.Gly324Glu | missense_variant | 7/11 | 2 | ENSP00000359097 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 3AN: 59878Hom.: 0 Cov.: 1 FAILED QC
GnomAD3 genomes
AF:
AC:
3
AN:
59878
Hom.:
Cov.:
1
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000470 AC: 6AN: 127776Hom.: 0 AF XY: 0.0000289 AC XY: 2AN XY: 69180
GnomAD3 exomes
AF:
AC:
6
AN:
127776
Hom.:
AF XY:
AC XY:
2
AN XY:
69180
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000643 AC: 49AN: 761862Hom.: 0 Cov.: 17 AF XY: 0.0000683 AC XY: 26AN XY: 380668
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
49
AN:
761862
Hom.:
Cov.:
17
AF XY:
AC XY:
26
AN XY:
380668
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000501 AC: 3AN: 59878Hom.: 0 Cov.: 1 AF XY: 0.0000341 AC XY: 1AN XY: 29294
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
3
AN:
59878
Hom.:
Cov.:
1
AF XY:
AC XY:
1
AN XY:
29294
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2021 | The c.971G>A (p.G324E) alteration is located in exon 7 (coding exon 6) of the AMY1B gene. This alteration results from a G to A substitution at nucleotide position 971, causing the glycine (G) at amino acid position 324 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
.;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D
MetaSVM
Benign
T
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Pathogenic
D;D
Vest4
MutPred
Gain of relative solvent accessibility (P = 0.09);Gain of relative solvent accessibility (P = 0.09);
MVP
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at